Gastroenterology
Volume 138, Issue 4 , Pages 1502-1513 , April 2010

Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis

  • Alexandra–Chloé Villani

      Affiliations

    • Division of Gastroenterology, Department of Medicine, McGill University, Montréal, Québec, Canada
    • McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada
    • Corresponding Author InformationReprint requests Address requests for reprints to: Alexandra-Chloé Villani, PhD, McGill University and Génome Québec Innovation Centre, 740, Doctor Penfield Avenue, Room 7500, Montréal, Québec H3A 1A4, Canada. fax: 514-398-1795
    • ,
  • Mathieu Lemire

      Affiliations

    • Ontario Institute for Cancer Research, Toronto, Ontario, Canada
    • ,
  • Marroon Thabane

      Affiliations

    • Farncombe Family Digestive Health Research Institute and Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Alexandre Belisle

      Affiliations

    • McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada
    • ,
  • Geneviève Geneau

      Affiliations

    • McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada
    • ,
  • Amit X. Garg

      Affiliations

    • Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada
    • ,
  • William F. Clark

      Affiliations

    • Division of Nephrology, Department of Medicine, University of Western Ontario, London, Ontario, Canada
    • ,
  • Paul Moayyedi

      Affiliations

    • Farncombe Family Digestive Health Research Institute and Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Stephen M. Collins

      Affiliations

    • Farncombe Family Digestive Health Research Institute and Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • ,
  • Denis Franchimont

      Affiliations

    • Division of Gastroenterology, Department of Medicine, McGill University, Montréal, Québec, Canada
    • Department of Gastroenterology, Erasme Hospital, Free University of Brussels, Brussels, Belgium
    • ,
  • John K. Marshall

      Affiliations

    • Farncombe Family Digestive Health Research Institute and Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada
    • Corresponding Author InformationJohn K. Marshall, MD, MSc, FRCPC, AGAF Division of Gastroenterology (Room 2F59), McMaster University Medical Centre, 1200 Main Street West, Hamilton Ontario L8N 3Z5, Canada. fax: 905-523-6048

Received 5 June 2009 ,Accepted 28 December 2009.

References 

  1. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45(Suppl 2):II43–II47
  2. Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol. 2003;98:1578–1583
  3. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology. 2003;124:1662–1671
  4. Chaudhary NA, Truelove SC. The irritable colon syndrome (A study of the clinical features, predisposing causes, and prognosis in 130 cases). Q J Med. 1962;31:307–322
  5. Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10:299–309
  6. McKendrick MW, Read NW. Irritable bowel syndrome—post salmonella infection. J Infect. 1994;29:1–3
  7. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000;47:804–811
  8. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut. 1999;44:400–406
  9. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003;52:523–526
  10. Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther. 2007;26:535–544
  11. Saito YA, Talley NJ. Genetics of irritable bowel syndrome. Am J Gastroenterol. 2008;103:2100–2104
  12. Tabor HK, Risch NJ, Myers RM. Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet. 2002;3:391–397
  13. Marshall JK, Thabane M, Garg AX, et al. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006;131:445–450
  14. Garg AX, Moist L, Matsell D, et al. Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking water. CMAJ. 2005;173:261–268
  15. Garg AX, Macnab J, Clark W, et al. Long-term health sequelae following E. coli and campylobacter contamination of municipal water (Population sampling and assessing non-participation biases). Can J Public Health. 2005;96:125–130
  16. Garg AX, Marshall J, Salvadori M, et al. A gradient of acute gastroenteritis was characterized, to assess risk of long-term health sequelae after drinking bacterial-contaminated water. J Clin Epidemiol. 2006;59:421–428
  17. Talley NJ, Phillips SF, Melton J, et al. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;111:671–674
  18. Thompson WG, Creed FH, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gastroenterol Int. 1992;5:75–91
  19. van den Boom D, Ehrich M. Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS. Methods Mol Biol. 2007;366:287–306
  20. Whitcombe D, Brownie J, Gillard HL, et al. A homogeneous fluorescence assay for PCR amplicons: its application to real-time, single-tube genotyping. Clin Chem. 1998;44:918–923
  21. Taylor J, Tyekucheva S, King DC, et al. ESPERR: learning strong and weak signals in genomic sequence alignments to identify functional elements. Genome Res. 2006;16:1596–1604
  22. de Bakker PI, Yelensky R, Pe'er I, et al. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–1223
  23. Xu H, Shete S. Mixed-effects logistic approach for association following linkage scan for complex disorders. Ann Hum Genet. 2007;71:230–237
  24. McPeek MS, Wu X, Ober C. Best linear unbiased allele-frequency estimation in complex pedigrees. Biometrics. 2004;60:359–367
  25. Thornton T, McPeek MS. Case-control association testing with related individuals: a more powerful quasi-likelihood score test. Am J Hum Genet. 2007;81:321–337
  26. Wagner H. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv Immunol. 1999;73:329–368
  27. Li LC, Chui RM, Sasaki M, et al. A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 2000;60:873–876
  28. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL6) gene on IL6 transcription and plasma IL6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest. 1998;102:1369–1376
  29. Heesen M, Bloemeke B, Heussen N, et al. Can the interleukin-6 response to endotoxin be predicted? (Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokines). Crit Care Med. 2002;30:664–669
  30. Qi L, van Dam RM, Meigs JB, et al. Genetic variation in IL6 gene and type 2 diabetes: tagging-SNP haplotype analysis in large-scale case-control study and meta-analysis. Hum Mol Genet. 2006;15:1914–1920
  31. Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three US ethnic groups and exploratory case-control disease association studies. Genomics. 2003;81:85–91
  32. Wu S, Rhee KJ, Zhang M, et al. Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and gamma-secretase-dependent E-cadherin cleavage. J Cell Sci. 2007;120:1944–1952
  33. Frank CF, Hostetter MK. Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans. Transl Res. 2007;149:211–222
  34. Barbara G. Mucosal barrier defects in irritable bowel syndrome (Who left the door open?). Am J Gastroenterol. 2006;101:1295–1298
  35. Marshall JK, Thabane M, Garg AX, et al. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario. Aliment Pharmacol Ther. 2004;20:1317–1322
  36. Dunlop SP, Hebden J, Campbell E, et al. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes. Am J Gastroenterol. 2006;101:1288–1294
  37. Stemmler MP, Hecht A, Kemler R. E-cadherin intron 2 contains cis-regulatory elements essential for gene expression. Development. 2005;132:965–976
  38. COGENT Study. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet. 2008;40:1426–1435
  39. The UK IBD Genetics Consortium & the Wellcome Trust Case Control Consortium 2. Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region. Nat Genet. 2009;41:1330–1336
  40. Muise AM, Walters TD, Glowacka WK, et al. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease. Gut. 2009;58:1121–1127
  41. Bisping G, Lügering N, Lütke-Brintrup S, et al. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells. Clin Exp Immunol. 2001;123:15–22
  42. Cario E, Becker A, Sturm A, et al. Peripheral blood mononuclear cells promote intestinal epithelial restitution in vitro through an interleukin-2/interferon-gamma-dependent pathway. Scand J Gastroenterol. 1999;34:1132–1138
  43. Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol. 1995;20:123–126
  44. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913–920
  45. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20:709–760
  46. Ewaschuk JB, Backer JL, Churchill TA, et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun. 2007;75:2572–2579

 Conflicts of interest The authors disclose no conflicts.

 Funding This research was supported by grants to DF and JKM from the Crohn's & Colitis Foundation of Canada (CCFC) and the Ontario Ministry of Health and Long-Term Care. Role of the Sponsors: The funding agencies had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.

PII: S0016-5085(09)02246-X

doi: 10.1053/j.gastro.2009.12.049

Gastroenterology
Volume 138, Issue 4 , Pages 1502-1513 , April 2010

Article Tools

* Image Usage & Resolution